MedPath

A randomized controlled trial for beta agonist on ulolithiasis patients associated with overactive bladder.

Phase 2
Conditions
urolithiasis
Registration Number
JPRN-UMIN000010553
Lead Sponsor
Department of Urology, Isehara Kyodo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) patients already receiving beta agonists 2) patients addicted to alcohol or drugs 3) contraindications cases of experimental drugs 4) pregnant or lactating women 5) individuals who are diagnosed as inappropriate for the trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stone free ratio after administration of drugs
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath